Biotron LimitedASX: BIT

Rights Issue Closed

· Issued by Biotron Limited

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Biotron Limited has announced the successful completion of its renounceable rights issue, which has now closed, raising funds before costs. The funds raised will support the company's commercialization activities and ongoing operational costs, particularly for its antiviral programs. The announcement has been approved by the Board of Directors and reflects strong support from shareholders and management.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Biotron Limited on 6ix

Story so far

Earlier from Biotron

Later from Biotron

All Biotron news releases